Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management.

Sykuta A, Yoon CH, Baldwin S, Rine NI, Young M, Smith A

Open source

DOI
10.1177/10600280231180000
Published
2024 Mar
Container
The Annals of pharmacotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10600280231180000,
  title = {Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management.},
  author = {Sykuta A and Yoon CH and Baldwin S and Rine NI and Young M and Smith A},
  year = {2024},
  journal = {The Annals of pharmacotherapy},
  doi = {10.1177/10600280231180000},
  url = {https://doi.org/10.1177/10600280231180000}
}

RIS

TY  - JOUR
TI  - Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management.
AU  - Sykuta A
AU  - Yoon CH
AU  - Baldwin S
AU  - Rine NI
AU  - Young M
AU  - Smith A
PY  - 2024
JO  - The Annals of pharmacotherapy
DO  - 10.1177/10600280231180000
UR  - https://doi.org/10.1177/10600280231180000
ER  - 

APA

A, S., CH, Y., S, B., NI, R., M, Y., & A, S. (2024). Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management.. The Annals of pharmacotherapy. https://doi.org/10.1177/10600280231180000

Source records